Unknown OBSERVATIONAL NCT05127798

RWE of 1st Line Treatment in Adults With AML From 18 to 70 Years Old.

Real World Evidence of First Line Treatment With Intensive Chemotherapy in Adult Patients With Acute Myeloid Leukemia From 18 to 70 Years Old

Sponsor: Grupo Argentino de Tratamiento de la Leucemia Aguda

Conditions Acute Myeloid Leukemia, Adult

Interventions Evaluation of first line treatment with intensive treatment outcome in adult patients with AML.

Updated 5 times since 2021 Last updated: Nov 9, 2021 Started: Mar 1, 2021 Primary completion: Mar 1, 2024 Completion: Dec 1, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Acute Myeloid Leukemia, Adult and is currently ongoing. Grupo Argentino de Tratamiento de la Leucemia Aguda leads this study, which shows 5 recorded versions since 2021 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

5 versions recorded

Sep 2025 — Present [monthly]

Unknown
Jan 2025 — Sep 2025 [monthly]

Unknown

Status: Recruiting → Unknown
Sep 2024 — Jan 2025 [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting
Dec 2021 — Jul 2024 [monthly]

Recruiting

First recorded

Mar 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Grupo Argentino de Tratamiento de la Leucemia Aguda

Data source: Grupo Argentino de Tratamiento de la Leucemia Aguda

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• CABA, Argentina
• La Plata, Argentina